CS Paper Radar

Beyond AUC: Do Mammography Risk Models Predict When Cancer Occurs?

Svetlana Krasnova, Andrey Krylov, Dmitry Sorokin

cs.CV q-bio.QMeess.IV ·submitted 2026-11-15 22:08 UTC · v1

Abstract

Longitudinal deep learning models for mammography-based breast cancer risk prediction output either per-year cumulative risks or a discrete distribution over the year of diagnosis, from which cumulative risks F1,...,F5 are derived. These models are evaluated almost exclusively with year-wise AUCs and the concordance index. We show that these metrics are largely insensitive to when cancer occurs: they can be high even for a model that carries no information about the year of diagnosis. We re-evaluate two recent longitudinal models (OA-BreaCR, LMV-Net) on CSAW-CC with a 5-year horizon using timing metrics computed on cancer cases only. Despite C-indices up to 0.75, neither orders cancer cases by time to diagnosis significantly better than chance (c_time 0.51 and 0.55, both 95% CIs covering 0.5). Weighted absolute timing error favours a constant "year 3" prediction over both models, so we use c_time as the primary timing metric. For Mirai's additive-hazard head, also used by LMV-Net, we analyse how per-year increments passed through a ReLU can collapse under severe class imbalance. We also propose a breast-level, two-stage model that separates whether from when. It matches LMV-Net in discrimination (C-index 0.745 vs. 0.746) but orders cancer cases better (c_time 0.58 vs. 0.51, paired 95% CI of the difference 0.01-0.13), on par with Mirai's published weights (0.57).

Comment
7 pages, 2 figures, 1 table. Submitted to ISBI 2027

Closest papers

Nearest neighbours by meaning across the whole index.

SideAge-RiskNet: Predicted Mammographic-Age Features for Future Breast Cancer Risk and Laterality Prediction

eess.IV ·2026-11-04 ·Haoyan Ding, Encheng Su, Chaowei Wu, Lixia Wang, Qian Wang +4 more
similarity 0.70
Abstract · 5 pages, 2 figures

Whether breast-specific mammographic aging provides information beyond chronological age for future cancer prediction remains unclear. We propose SideAge-RiskNet, a framework integrating predicted mammographic-age features with breast-specific representations for multi-year breast cancer risk and conditional laterality prediction. A side-aware DenseNet121 trained on never-cancer reference examinations estimates left and right breast ages. Age-adjusted residuals and bilateral age descriptors are subsequently fused with corresponding image representations, while clinical variables contribute through an image--clinical risk branch. The framework jointly predicts cumulative cancer risk over 1--5 years and the subsequently affected breast among unilateral cancer cases. Across 4,480 EMBED and 248 external examinations, pre-cancer scans demonstrated pronounced bilateral age asymmetry. SideAge-RiskNet established state-of-the-art performance in 1--5-year risk assessment over Mirai and AsymMirai with mean risk AUROCs of 81.73% on EMBED and 72.83% on CSMC. Furthermore, it enabled conditional cancer laterality prediction, achieving AUROCs of 73.26% and 82.53%, respectively. This demonstrates the critical utility of bilateral aging phenotypes in localized breast cancer risk surveillance.

0.20

Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy Using Temporal Deep Learning on DWI

cs.AI ·2026-08-18 ·Pablo García Marcos, Md. Tarequl Islam, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez +3 more
similarity 0.66
Abstract

Early identification of non-responders to neoadjuvant chemotherapy (NACT) is crucial for timely treatment adaptation in breast cancer. However, many existing predictive models rely on multiparametric magnetic resonance imaging (MRI), late treatment time points, or extensive clinical data, which limits their applicability. This study proposes a deep learning framework for early prediction of pathological complete response (pCR) using only diffusion-weighted MRI (DW-MRI) acquired at baseline and after the first NACT cycle. This framework feeds cropped tumor-centered patches to an EfficientNet-based temporal model that directly learns tumor shape and local tissue characteristics without explicit radiomic feature engineering. The model, trained with 10-fold cross-validation, achieved an area under the receiver operating characteristic curve (AUC) of 0.90 for pCR prediction after one cycle, providing actionable information after a single treatment cycle while avoiding gadolinium administration and reducing dependence on heterogeneous clinical data. By focusing on the baseline-to-first-cycle window instead of later stages, the approach supports earlier escalation or de-escalation of NACT, and its exclusive reliance on DW-MRI facilitates protocol standardization, multi-centre deployment and privacy-preserving data sharing. These results demonstrate that DW-MRI-based deep learning on tumor-centered patches constitutes a minimally invasive, clinically deployable strategy for early pCR prediction, with direct implications for personalized treatment adaptation in neoadjuvant breast cancer therapy.

0.21

CACSurv: Concordance-Aligned Comparative Learning with Large Language Models for Cancer Survival Prediction

cs.AI ·2026-08-17 ·Tianqi Xiang, Qixiang Zhang, Xinpeng Ding, Yi Li, Xiaomeng Li
benchmarkcode/data similarity 0.65
Abstract

Cancer survival prediction supports treatment planning, risk stratification, and follow-up management. Existing methods use structured clinical variables, whole-slide images, genomic profiles, or multimodal inputs, while patient reports remain underexplored. We study report-centric survival prediction using reports that organize pathological, clinical, and molecular evidence. Large language models (LLMs) can reason over such reports, but case-wise time regression introduces two mismatches. First, a formulation mismatch arises because survival evaluation depends on ordering comparable patients, whereas independent time predictions do not enforce ranking consistency. Second, a supervision mismatch arises because a censored patient's observed time indicates survival beyond that point and cannot serve as an exact regression target, although it still implies orderings relative to patients who died earlier. To address these mismatches, we propose CACSurv, a Concordance-Aligned Comparative framework for report-centric survival prediction. CACSurv reformulates survival modeling as mini-cohort comparative reasoning, where an LLM predicts relative prognostic orderings. We introduce concordance-aligned rewards derived from comparable relations under right censoring, enabling censored outcomes to provide ranking supervision without exact event-time targets. At inference, Monte Carlo Reference Aggregation compares each patient with sampled references and aggregates positions into a cohort-level ranking. We establish TCGA-SurvReport, a benchmark covering six TCGA cancer cohorts. CACSurv achieves the highest C-index on all six cohorts and an average C-index of 0.722, outperforming the strongest published survival model by 6.5 percentage points and the strongest LLM time-regression baseline by 4.2 percentage points. Our code, models, and dataset will be available at https://github.com/xmed-lab/CACSurv.

0.52

Scalable Clinical Data Infrastructure and Comparative ML Evaluation for Hospitalisation Risk Prediction in Elderly Patients with Multiple Long-Term Conditions using CPRD

cs.LG cs.AI ·2026-08-29 ·Asra Aslam, Volodymyr Chapman, Maurice M. O'Connell, Aseel S. Abuzour, Michael Abaho +7 more
benchmarkposition similarity 0.64
Abstract

Deep learning architectures are increasingly proposed for patient trajectory modeling in electronic health records (EHRs), yet their advantage over simpler, more interpretable models is rarely subjected to rigorous empirical scrutiny in real-world clinical settings. We present a comprehensive patient timeline pipeline applied to elderly patients in CPRD Aurum, incorporating 260 clinical conditions classified via a three-tier automated framework including specialised detection logic for 17 complex conditions. Using this infrastructure, we benchmark Temporal Graph Convolutional Neural Networks (TG-CNN) against Logistic Regression with LASSO regularisation and Random Forests for predicting 12-month all-cause emergency hospitalisation risk, motivated by (but not filtered to) the elevated risk of adverse drug reactions. Under cross-validation, TG-CNN achieves a marginally higher mean AUC-ROC than LASSO (0.712 vs. 0.705), whereas on the held-out test set LASSO achieves the highest discrimination of three models (AUC-ROC 0.733, versus 0.710 for Random Forest and 0.702 for TG-CNN). We show, that discrimination alone is an incomplete criterion for clinical deployment: after Platt calibration, LASSO is the only model with an acceptable calibration slope (0.817), while Random Forest (0.759) and, TG-CNN (0.391) remain substantially miscalibrated. We argue that LASSO, not the highest-discriminating model, is the model best suited to direct clinical deployment. We present lessons for the machine learning and healthcare community regarding data infrastructure, model selection, and value of calibration and interpretability in high-stakes decision support.

0.17

Explicitly Aligned Multi-View Breast Cancer Risk Prediction from Variable-Length Screening Histories

cs.CV cs.AI ·2026-10-12 ·Solveig Thrun, Zijun Sun, Suaiba A. Salahuddin, Kristoffer Wickstrøm, Elisabeth Wetzer +3 more
benchmarkcode/data similarity 0.64
Abstract

Accurate breast cancer risk prediction from screening mammography is essential for improved risk stratification and personalized screening. It can benefit from both temporal breast tissue changes across longitudinal examinations and complementary anatomical information from craniocaudal (CC) and mediolateral oblique (MLO) views. Leveraging longitudinal information requires identifying corresponding tissue regions across examinations, yet most approaches rely on implicit feature alignment without explicitly enforcing spatial consistency. Recent work has demonstrated the benefits of explicit temporal alignment; however, existing methods model each view independently, preventing them from exploiting complementary CC and MLO information. Furthermore, explicit approaches have been limited to a single prior examination. To fill these gaps, we propose (github.com/sot176/FlexLMV-Net), a breast-wise longitudinal multi-view framework that jointly models CC and MLO views across screening examinations while accommodating a variable number of prior examinations. FlexLMV-Net explicitly aligns longitudinal feature maps and integrates complementary views through cross-view temporal fusion and a dual-stream attention block. Evaluated on EMBED and CSAW-CC, FlexLMV-Net consistently outperforms existing approaches across breast density, cancer subtypes, and demographic subgroups, highlighting the benefits of explicit longitudinal alignment, multi-view modeling, and flexible use of available screening history. We further introduce (github.com/sot176/BCRBench), an open-source benchmark that unifies state-of-the-art single- and multi-timepoint breast cancer risk prediction models under standardized preprocessing, training, inference, and evaluation protocols, enabling fair and reproducible comparison of existing methods.

0.25

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.63
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19

The Loss or the Architecture? What Matters in Survival Analysis with Competing Risks

cs.LG stat.ML ·2026-10-16 ·Julie Alberge, Gaël Varoquaux, Judith Abécassis
benchmark similarity 0.62
Abstract

Often, \emph{eg} in healthcare and predictive maintenance, what matters is which of several competing causes will strike first, and with what probability: survival analysis with competing risks. Corresponding deep learning methods are developed as bundles: a new architecture together with a new training loss, tested on one to five datasets against a handful of baselines. Thus, a state-of-the-art result cannot be attributed to the architecture, the loss, or the evaluation protocol. The coupling is not accidental: with one incidence curve per cause, a network's head is tied to the losses expressible on it. We vary the two axes independently, three losses, two of them strictly proper, on four backbones, across two modalities that tease the axes apart: 20 tabular and 3 pathology-image datasets. One loss wins in both: modelling cumulative incidence directly under censoring weighting. It brings twice as much as benefits a good choice of backbone on competing-risks data, and no more than it on single-event data: the loss is decisive for competing risks. The backbone matters too, and must match the modality: tabular networks lead on tables, pretrained vision encoders on images. The two choices compound rather than substitute. Proper scoring rules reveal these dynamics; the concordance index (C-index), which is not proper, does not separate models: neither axis moves it, not even tuning on the loss built to improve it. This is an avenue of progress: composed, the two give a model nobody has tried, RealMLP or TabM trained with the cumulative-incidence loss, which takes the best Brier score in our benchmark.

0.24

Extending the Horizon of Early Diagnosis: Lung Cancer Prediction with Vision Transformers

cs.CV ·2026-08-21 ·Olivera Kotevska, Ian Goethert, Michael McGee, Maria Mahbub, Sean R. Wilkinson +9 more
similarity 0.62
Abstract

Lung cancer remains a leading cause of cancer-related mortality worldwide, and early diagnosis is critical for improving survival. However, early-stage malignancies can be subtle on chest X-rays, creating challenges for radiologists. This study evaluates Vision Transformers (ViTs) for predicting lung cancer one to two years before clinical diagnosis. We analyzed 259,361 chest X-rays from 91,020 imaging studies at the Jamaica Plains VA Hospital in Boston, MA. The dataset showed extreme class imbalance, approximately 1:150 cancer to non-cancer, which was addressed using hybrid under- and over-sampling and class-weighted loss optimization. Three ViT configurations were evaluated: a model trained from scratch, an ImageNet-pretrained model, and a Corona-pretrained model fine-tuned on the lung cancer dataset. Transfer learning improved performance, with pretrained models exceeding the scratch baseline by 6-10 percentage points in AUC and about 10-12 percent in balanced accuracy. ImageNet-pretrained models showed the most stable overall performance, while Corona-pretrained models achieved higher sensitivity in some settings but greater variability. Moderate resampling ratios, including 1:1 undersampling and 1.5:2 oversampling, provided favorable trade-offs between sensitivity, precision, and computational efficiency, reducing runtime by up to 70 percent without major performance loss. These findings demonstrate the potential of ViTs for early lung cancer risk prediction from routine chest X-rays. Although performance remains below clinical deployment thresholds, the results support further development of ViT-based triage systems to flag high-risk patients for earlier evaluation.

0.09